COVID-19

The microbiome is a dynamic environment that can give researchers the inside scoop on health and disease.

While covid has caused illness and millions of deaths among humans, multiple nonhuman animal species have turned out to be susceptible to it, too.

An expert panel will discuss mRNA-based vaccines, current approaches and challenges, and how researchers are moving RNA therapeutics forward in exciting new directions.

Lateral flow tests for COVID-19 can be very accurate and specific when used as directed, but introducing acidic fluids can cause the tests’ detecting antibodies to clump, which may read as a positive result.

In this webinar, Grégoire Lauvau and Marcus Buggert will discuss the function and role of memory T cells in health and disease.

Microbial diversity in the infant gut shrank suddenly during the first lockdown, but the lasting health effects are less clear.

Natalie Knox and the Public Health Agency of Canada’s National Microbiology Laboratory are helping establish a national qPCR-driven wastewater surveillance network for SARS-CoV-2 and other diseases.

Katalin Karikó and Drew Weissman received this year’s Physiology or Medicine award for their work on RNA biology and mRNA-based vaccines.

Scientists present the latest research on infection prevention and treatment, including COVID-19 and tropical infectious diseases.

Vaccination against one SARS-CoV-2 variant can yield antibodies with efficacy against other viral variants.

A nucleic acid detection platform that marries CRISPR diagnostic tools with bioluminescence could accelerate treatment decisions in the clinic.

Ana Teresa Freitas discussed how individual variation in vitamin D synthesis and metabolism influences susceptibility to upper respiratory viruses.

Male patients who recover from mild COVID-19 have baseline immune states primed to mount stronger responses to future challenges than female patients.

mRNA-encoded self-assembling enveloped virus-like particles presenting SARS-CoV-2 spike protein enhance immunity and may provide better protection against viral variants. 

Jie Sun shares how his curiosity, creativity, and motivation to address clinical public health needs steer his research in immunology and infectious disease.

Researchers shed light on the immunometabolism of respiratory infection, providing an avenue towards safer COVID-19 therapeutics for those affected by metabolic disorders.

Michael Wiley will discuss detecting pathogens in communities through wastewater surveillance programs.

Scientists present the latest research on the immune response against SARS-CoV-2, the influence of COVID-19 on future vaccine responses, and drivers of T cell development.

A new study relying on DNA methylation clocks suggests that the biological age of mouse and human cells can fluctuate in response to stressful events.